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Chondrogenic differentiationNucleus pulposus (NP) tissue damage can induce detrimental mechanical stresses and strains on the
intervertebral disc, leading to disc degeneration. This study demonstrates the potential of a novel,
photo-curable, injectable, synthetic polymer hydrogel (pHEMA-co-APMA grafted with polyamidoamine
(PAA)) to encapsulate and differentiate human mesenchymal stem cells (hMSC) towards a NP phenotype
under hypoxic conditions which could be used to restore NP tissue function and mechanical properties.
Encapsulated hMSC cultured in media (hMSC and chondrogenic) displayed good cell viability up to day
14. The genotoxicity effects of ultraviolet (UV) on hMSC activity confirmed the acceptability of 2.5 min of
UV light exposure to cells. Cytotoxicity investigations revealed that hMSC cultured in media containing
p(HEMA-co-APMA) grafted with PAA degradation product (10% and 20% v/v concentration) for 14 days
significantly decreased the initial hMSC adhesion ability and proliferation rate from 24 hrs to day 14.
Successful differentiation of encapsulated hMSC within hydrogels towards chondrogenesis was observed
with elevated expression levels of aggrecan and collagen II when cultured in chondrogenic media under
hypoxic conditions, in comparison with culture in hMSC media for 14 days. Characterization of the
mechanical properties revealed a significant decrease in stiffness and modulus values of cellular hydro-
gels in comparison with acellular hydrogels at both day 7 and day 14. These results demonstrate the
potential use of an in vivo photo-curable injectable, synthetic hydrogel with encapsulated hMSC for
application in the repair and regeneration of NP tissue.
 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved. This is an open access article
under the CC BY license (http://creativecommons.org/licenses/by/3.0/).1. Introduction
Changes in the composition and properties of nucleus pulposus
(NP) can cause changes in the mechanical stresses and strains and
physiological loads applied, which subsequently result in disc
degeneration and back pain [1]. Biochemical changes that occur
within damaged NP tissue include: a decrease in large proteogly-
cans (PG), an increase in collagen I and an increase in the ratio of
small to large PG, resulting in a more fibrous NP tissue [1]. The
NP is also avascular, is thought to have a high concentration of lac-
tic acid [2] and is moderately acellular, with only 5000 cells mm3compared with the annulus fibrosus, which has 9000 cells mm3
[3]. Moreover, cells in the NP rely solely on diffusion of nutrients
from adjacent endplates, and therefore natural repair of damaged
NP tissue is a difficult and inefficient process [3].
Recently, many researchers have attempted to combine the
effect of tissue engineering strategies with stem cell biology to
act as a potential therapy to restore the function and properties
of NP tissue. Cells in NP are of a rounded morphology and resemble
typical chondrocytes located in articular cartilage [4]. Owing to the
limited availability of NP cells within the actual tissue [5], an
alternative cell type may be required. Stem cells such as bone
marrow-derived human mesenchymal stem cells (hMSC) offer great
therapeutic opportunities, given their characteristics of multipo-
tential differentiation capacity, including chondrogenic lineages.
HMSC are also immunopriviliged [6] and have the ability to expand
into adequate cell numbers relevant for NP tissue purposes.
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sue engineering applications because of their hydrated nature
and ability to mimic the natural structure of in vivo tissue environ-
ments. Hydrogels provide properties such as biocompatibility, a
flexible method of formation, anticipated physical characteristics,
the provision of structural integrity to tissue constructs, essential
structural and compositional similarities to extracellular matrix
(ECM) and an extensive framework, which provides cellular prolif-
eration and survival, making them the ideal candidate for cell
delivery and to function as a temporary support for NP tissue
regeneration [7]. There have been a limited number of studies
attempting to encapsulate hMSC and drive their differentiation
towards a NP lineage. Of the studies that do exist, natural polymers
have been the popular choice, including alginate [8,9], hyaluronan
gel [10], collagen [11], thermoresponsive hyaluronic acid [12] and
chitosan-glycerophosphate [5]. Natural polymers pose limitations
such as batch variation in tissue and immune responses [13]. For
this reason, recent attempts have included incorporating or using
synthetic polymers through alternative fabrication techniques
such as photo-crosslinking for the production of hydrogels.
Puramatrix™ is an example of a commercial, synthetic hydrogel
that encapsulates hMSC [10]. The advantage of using synthetic
polymers over natural polymers [14] is the ability to control and
tailor the mechanical properties as well as dictate degradation
profiles to match the rate of matrix production.
Benefits of using photopolymerization over the reversible nat-
ure of conventional chemical and ionic crosslinking techniques
[13] include short reaction times, minimal heating, not requiring
organic solvents, and relatively easy tuning of the materials to pro-
vide the desired mechanical properties and swelling behaviour
[15]. Photocrosslinking can result in hydrogels that could promote
optimal performance for NP tissue regeneration and temporary
disc height support. Attempts to use photocurable hydrogels for
application in NP tissue engineering have included: a two-phase
hydrogel; N-methacrylate glycol chitosan and star-poly-e-capro-
lactone-co-D,L-lactide triacrylate [16] and carboxymethylcellulose
[13,17], where encapsulated NP cells demonstrated good cell
viability and successful maintenance of the NP phenotype.
Furthermore, chondrocytes have also been encapsulated and
cultured in photocurable hydrogels produced from polyethylene
glycol [18] and degradable lactic acid in polyethylene glycol [19].
Articular cartilage foetal cells, interstitial cartilage foetal cells and
bone foetal cells have all also been investigated within a
Tween-20 methacrylate T3 and N-vinyl-2-pyrrolidone photocur-
able hydrogel [20]. However, one study has also attempted to
encapsulate and drive MSC differentiation towards NP phenotype
using a photocurable hydrogel fabricated from polyethylene glycol
diacrylate (PEGDA). The study demonstrated successful differenti-
ation and good expression of GAG and Coll II [21].
Enhancing differentiation ability of hMSC towards an NP cell
type can be made possible by combining the effects of hMSC expo-
sure to low levels of oxygen and mimicking the three-dimensional
(3-D) ECM environment through hydrogels. Native NP tissue is
hypoxic and, therefore, much of the metabolic energy is acquired
through the glycolytic pathway. Hence, hypoxic conditions can
heavily influence the differentiation of hMSC towards an NP cell
phenotype [8]. Furthermore, it is well known that culturing stem
cells [22] under hypoxic conditions significantly enhances their
differentiation ability [9,23,24]. Therefore, mimicking the native
hypoxic conditions may prove beneficial for differentiating hMSC
towards a NP cell type in combination with additional cues,
chemically and structurally. This cell culturing method has been
attempted by Stoyanov et al. [9], where the effect of hypoxia,
chondrogenic growth factors and co-culture with bovine NP cells
was investigated on hMSC differentiation to NP cells when
encapsulated in alginate beads [9].This study investigates the effectiveness of encapsulating bone
marrow-derived hMSC in a novel 3-D photo-curable, biodegradable
synthetic polymer hydrogel, polyhydroxyl ethyl methacrylate-co-
N-(3-aminopropyl) methacrylamide grafted with polyamidoamine
(p(HEMA-co-APMA) g PAA). In addition to hMSC encapsulation
within hydrogels, it is hypothesized that the combined effects
of hypoxia and chondrogenic media culture conditions will
encourage the differentiation ability of hMSC towards a NP cell-like
phenotype.2. Materials and methods
2.1. Recovery, isolation and expansion of bone marrow-derived hMSC
Fresh human bone marrow aspirate (purchased from Lonza, UK)
was recovered, isolated and expanded as described previously by
Pittenger et al. [6]. Briefly, hMSC media consisted of DMEM, 10%
fetal bovine serum (FBS; Lonza, UK), 1% L-glutamine (L-Glut; Lonza,
UK), 1% non-essential amino acids (NEAA; Lonza, UK) and 1% pen-
icillin and streptomycin, and incubation during the whole process
took place in a hypoxic (2% O2), SCI-Tive workstation (RUSKINN
Technology, The Baker Company). Once recovered, isolated and
expanded hMSC were tryspinized and cryopreserved in liquid
nitrogen for future use.
2.2. Preparation of photo-curable hydrogel solution
The p(HEMA-co-APMA) g PAA polymer was prepared as
described previously [25]. Hydrogels were prepared at 13.5%
(w/v) concentration by dissolving the required amount of polymer
in phosphate buffered saline (PBS). A 50% (w/v) Irgacure 2959
(prepared using DMSO) solution was added to the polymer solu-
tion at 1 vol.% of the total polymer solution. The polymer solution
was briefly vortexed and sterile filtered before use.
2.3. hMSC encapsulation in hydrogels and hypoxic culture
The hMSC (Passage 3) were expanded using hMSC media under
2% O2 conditions. Cell seeding solutions were prepared at a density
of 200,000 cells/50 ll of hMSC media per hydrogel. Cell seeding
solution was combined with the polymer solution (pre-sterile
filtered), homogeneously mixed, and 300 ll volume was pipetted
into a well of a sterile 48-well plate (Corning, UK). Cells and hydro-
gel solution were exposed to UV light using a longwave UV lamp
(Black-ray B-100AP, high intensity, 100 W/365 nm) for 2.5 mins
from a distance of 10 cm. Acellular hydrogels were photo-cross-
linked using the same protocol, but without cells, as shown in
Fig. 1. Two-dimensional controls were also used where hMSC were
seeded at 100,000 cells well1 without UV exposure. Encapsulated
hMSC in p(HEMA-co-APMA) g PAA hydrogels and controls (tissue
culture plastic (TCP)) were cultured in either hMSC media or
chondrogenic media (consisting of DMEM, 1% FBS, 1% NEAA, 1%
L-glut, 0.1 lM dexamethasone, 50 lM ascorbic acid, 40 lg ml1
L-proline, 1% sodium pyruvate and 10 ng ml1 TGF-b3) and
incubated at 2% O2. Media changes took place every 2–3 days.
2.4. Genotoxicity effects of UV exposure on hMSC
The hMSC seeded at a density of 100,000 cells well1 were
exposed to UV light for 0, 2.5, 10 and 20 mins. Cells were then cul-
tured in hMSC media and incubated at 2% O2 for 24 hrs. The media
were removed, and cells were washed with PBS and fixed with 1%
methanol-free formaldehyde (prepared in PBS) at 0 C for 15 mins.
Fixative was aspirated off, and the cells were immersed in 70%
ethanol for 2 hrs at 20 C. Cells were washed twice in PBS and
Fig. 1. Schematic showing the process of photo-curing of hMSC encapsulated within p(HEMA-co-APMA) g PAA hydrogels: (A) procedure of 3-D hMSC encapsulation in
polymer to produce hydrogel; (B) representative image of a 13.5% (w/v) photo-cured hydrogel with dimensions 1 cm Ø and 3 mm thick).
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for a further 30 mins. Cells were then incubated overnight in 1%
bovine serum albumin (BSA) containing 5 lg ml1 mouse anti-
human phospho-histone monoclonal antibody (Ser139; Millipore,
UK) at 4 C. Finally, cells were washed twice with PBS and
incubated with Alexa Fluor 633 goat anti-mouse IgG conjugated
secondary antibody (1:100) for 30 mins at room temperature. Cells
were also counterstained with DAPI (1 lg ml1; prepared in PBS)
for 5 mins. Samples were imaged using a confocal microscope.
2.5. Cell viability: live/dead staining
Cell viability was investigated using a live/dead stain (FLUKA
Analytical, Sigma–Aldrich, UK) at day 7 and day 14 time points.
Media were removed from all cell–hydrogel samples and TCP
controls, washed twice with PBS and stained with calcein-AM
and propidium iodide solution as per the manufacturer’s instruc-
tions. Samples in staining solution were incubated at 37 C for
15–20 mins. The staining solution was removed, samples were
washed twice with PBS and immersed in PBS before imaging.
Imaging was performed with a confocal microscope using
490 nm/515 nm (excitation/emission) for calcein-AM and
535 nm/617 nm (excitation/emission) for propidium iodide.
2.6. Proliferative activity
Cell proliferation of hMSC cultured in p(HEMA-co-APMA) g PAA
hydrogels and in the monolayer was evaluated using Alamar blue
solution. Media (hMSC or chondrogenic) were removed at specific
time points (24 hrs, day 7 and day 14), washed with PBS (for
5 mins) and immersed in 10% Alamar blue solution (prepared in
hMSC media) for 90 mins and incubated at 37 C. Fluorescence
intensity was analysed at 570 nm/585 nm (excitation/emission)
using the Synergy II plate reader (Biotek, UK).
2.7. Immunocytochemistry of multipotent expression and
chondrogenic expression markers
Media were removed from hMSC encapsulated in p(HEMA-co-
APMA) g PAA hydrogels and expanded on a monolayer in both
media (hMSC and chondrogenic) for 7 and 14 days. Samples were
washed twice with PBS and fixed using 100% ethanol for 30 mins,
at room temperature. Samples were washed again with PBS, and
non-specific proteins were blocked with 2% BSA (prepared inPBS) for 1 hrs at room temperature. Samples were washed with
PBS before primary antibody treatment with: goat anti-human
aggrecan G1-IGD-G2 domains (20 lg ml1; R&D Biosystems, UK),
mouse anti-human collagen II (Coll II, 1 mg ml1; Abcam, UK),
mouse anti-human THY-1 (CD90, 1 mg ml1; Millipore, UK) and
mouse anti-human STRO-1 (1 mg ml1; Millipore, UK) and incu-
bated overnight at 4 C. Primary antibodies were carefully
removed, and the samples were washed with PBS and coated in
relevant secondary antibodies: for Coll II and Stro-1 (donkey
anti-mouse northern lights IgG; 10 lg ml1, NL557, R&D
Biosystems), Thy-1 (goat anti-mouse northern lights IgM;
10 lg ml1, NL493, R&D Biosystems) and aggrecan (rabbit anti-
goat IgG, Abcam, UK) and incubated at 37 C for 2 hrs. Secondary
antibody solution was removed, samples washed with PBS twice
and stored in PBS, before imaging using a confocal microscope
(Olympus Fluoview, FV5-PSU).
2.8. Cytotoxicity of p(HEMA-co-APMA) g PAA degradation products
The hMSC (20,000 cells well1) were plated and cultured in
hMSC media containing; 0%, 5% and 10% (v/v) of degraded
p(HEMA-co-APMA) g PAA polymer solution up to day 14 in physi-
ological normoxic conditions. Media (with 0%, 5% and 10%
degraded p(HEMA-co-APMA) g PAA polymer solution) were pre-
pared by adding the relevant volume of degraded polymer solution
in hMSC media prepared as stated in Section 2.3, as a total concen-
tration of the polymer in media. Media changes took place every
3 days. At time points (24 hrs, day 7 and day 14) media were
removed from cells, washed with PBS (twice) and immersed in
0.5 mg ml1 MTT assay solution (prepared in serum-free media)
for 4 hrs at 37 C. MTT solution was gently removed, and samples
were immersed in DMSO and incubated for 30 mins at 37 C. Sam-
ples were homogenously mixed and aliquoted into a 96-well plate
and absorbance read at 570 nm (Synergy II plate reader, Biotek).
2.9. Dynamic testing of mechanical property of acellular and cellular
hydrogels
The hMSC were encapsulated in 13.5% (w/v) p(HEMA-co-APMA)
g PAA hydrogels and cultured in both media types (hMSC and
chondrogenic) up to day 14; in parallel, acellular hydrogels were
also cultured in PBS under hypoxic conditions. Media changes took
place every 2–3 days. At time points (day 7 and day 14) media/PBS
were removed from the samples, and their mechanical properties
3466 D. Kumar et al. / Acta Biomaterialia 10 (2014) 3463–3474were characterized using the BOSE 3200 Series II test instrument
and dynamic mechanical analysis (DMA) software (Bose
Corporation, Electroforce Systems Group, Eden Prairie, MN, USA).
The mechanical properties (dynamic stiffness and elastic modulus)
of the samples were characterized under 5% compression at 1 Hz
frequency.
2.10. Acellular hydrogel degradation under compression
Acellular p(HEMA-co-APMA) g PAA hydrogels were produced as
previously described. Hydrogels were then exposed to a mechani-
cal stimulation regime of uniaxial compression of 5% strain at 1 Hz
for 900 cycles (15 mins) for 5 days a week, using the BOSE 3200
Series II test instrument, and then incubated back into PBS at
37 C. The swelling behaviour and the weight loss of these hydro-
gels were evaluated at days 0, 7, 14, 28 and 56, with n = 3 repeats.
At each time point, the swollen hydrogels were removed from the
PBS and blotted gently to remove excess PBS. Hydrogels were
washed in distilled water followed by ethanol 50% (v/v) and pure
ethanol for an hour in each, and dried overnight from ethanol
under a reduced pressure of 0.01 mbar. The swelling ability and
weight loss were calculated using the following equations:
Swelling degree % ¼ ðWs W0Þ  100=W0 ð1Þ
weight loss % ¼ ðW0 WdÞ  100=W0 ð2Þ
where W0, Ws and Wd are the initial, swollen and dried weight,
respectively.
2.11. Statistical analysis
Average and standard deviations were calculated from three
repeats on each sample, except for Alamar blue quantification data,
where triplicate readings were performed for each repeat. Error
bars on graphs represent one standard deviation (SD) in both
positive and negative orientations. Data were tested for normality
and a one-way ANOVA/Kruskall–Wallis test was performed,
followed by a Tukey’s post hoc test to determine the significance
of origin for all data in Figs. 2, 3, 6 and 8. Significance levels were
defined as: ⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001.
3. Results
3.1. Genotoxicity evaluation of UV exposure on hMSC
Expression of !H2aX was evaluated 24 hrs after hMSC were
exposed to 0, 2.5, 10 and 20 mins of UV during initial seeding.
The obvious increase in expression of !H2aX within hMSC with
prolonged duration of UV exposure was visualized via immunocy-
tochemistry. Quantification of !H2aX expression (performed by
counting the number of !H2aX expressing cells in comparison
with DAPI stained cells per field image using Image J) demon-
strated significant increases between time points. Insignificant
differences were observed between hMSC exposed to 0 mins and
2.5 mins of UV light. hMSC exposed to 2.5 mins of UV light resulted
in 10% of hMSC expressing !H2aX (Fig. 2). However, 10 mins
and 20 mins of UV exposure to hMSC resulted in a significant
increase in the number of cells expressing !H2aX with a 1.5-fold
and 7-fold increase, respectively (Fig. 2).
3.2. Cell viability and proliferation of encapsulated hMSC cultured
under hypoxic conditions
The hMSC encapsulated within p(HEMA-co-APMA) g PAA
hydrogels were cultured using two different media, hMSC andchondrogenic, up to day 14 in hypoxic conditions. Cell viability
observations showed a majority of viable cells at day 7 and day
14, which confirmed acceptable biocompatibility and an appropri-
ate 3-D environment that supported cell growth. Importantly,
live/dead analysis also provided observations on morphological
changes. It was witnessed that encapsulated hMSC within
p(HEMA-co-APMA) g PAA hydrogels cultured in hMSC media
exhibited typical hMSC morphology, which was fibroblastic and
spindle-like. However, when cultured in chondrogenic media, a
totally different morphology was observed (Fig. 3A). Cells appeared
to be much more rounded and larger in size. Quantification of cell
proliferation (Alamar blue) demonstrated a significant increase in
cell numbers from day 7 to day 14 between all sample types
(TCP and hydrogels in hMSC and chondrogenic media) (Fig. 3B).
At day 14, significantly greater number of cells (1.185-fold
increase) was observed on TCP when cultured in hMSC media in
comparison with cells on TCP in chondrogenic media. However,
among the hydrogels, a significant difference in cell numbers was
not observed when cultured in either hMSC or chondrogenic
media.
3.3. Multipotent and chondrogenic marker expression
The hMSC encapsulated in p(HEMA-co-APMA) g PAA hydrogels
were cultured in both hMSC and chondrogenic media up to day 14
in physiological normoxia (2% O2). Multipotent marker expression
was evaluated using immunocytochemistry, which demonstrated,
as expected, positive expression for Stro-1 and Thy-1(CD90) of
hMSC encapsulated in p(HEMA-co-APMA) g PAA gels and when
cultured on TCP in hMSC media at both day 7 and day 14
(Fig. 4). However, positive expression of both Stro-1 and
Thy-1(CD90) was also witnessed when hMSC were encapsulated
in pHEMA-APMA-PAA gels and also cultured on TCP in chondro-
genic media at both day 7 and day 14 (Fig. 4).
Chondrogenic marker expression was evaluated by detecting
expression of collagen II and aggrecan. As expected, the negative
controls (primary antibody staining without secondary and vice
versa) showed no expression of either collagen II or aggrecan.
Despite not being a strong signal, expression of collagen II and
aggrecan was visible for hMSC encapsulated in p(HEMA-co-APMA)
g PAA hydrogels and cultured on TCP in hMSC media at day 7 and
day 14 (Fig. 5). However, hMSC (cultured on TCP) in chondrogenic
media displayed increased levels of collagen II and aggrecan in
comparison with samples cultured in hMSC media at both time
points (day 7 and day 14). Furthermore, increasing levels of colla-
gen II and aggrecan were also witnessed from day 7 to day 14 in
both hydrogels and TCP samples in chondrogenic media (Fig. 5).
Interestingly, a change in cell morphology was also observed in
hMSC cultured on TCP in chondrogenic media in comparison with
hMSC media at both time points (day 7 and day 14), where cells
appear with a rounded morphology (in chondrogenic media) and
fibroblastic-like morphology in hMSC media. Furthermore, it is
apparent that aggregates or condensation-like features are formed
at day 14 in hMSC encapsulated hydrogels cultured in chondro-
genic media, as shown in Figs. 4C, D and 5C, D.
3.4. Evaluation of cytotoxicity of p(HEMA-co-APMA) g PAA
degradation products
Live/dead staining observations demonstrated the delay in
initial adhesion and spreading of hMSC to TCP with increasing
p(HEMA-co-APMA) g PAA monomer concentration in culture
media after 24 hrs in culture (Fig. 6A). After a 14-day culture per-
iod, live/dead staining showed an increase in cell numbers within
the observed field, with retention of hMSC morphology (typically
fibroblastic) in all three media conditions. Quantification of cell
Fig. 2. Effect of UV exposure on hMSC DNA damage evaluated by the expression of !-H2AX: (A) Top row: light microscopy images representing cell morphology and
adhesion (scale bar = 200 lm); Middel and bottom rows: confocal immunofluorescence microscopy images of hMSC stained for !-H2AX after exposure to 0, 2.5, 10 and
20 min to UV and then cultured on TCP for 24 h in hMSC media; (B) quantification of the number of rounded hMSC 24 h after being exposed to different exposure times of UV.
Values indicate average % of !-H2AX expressing cells and error bars indicate SD of n = 3 repeats. Data were tested for normality and a one-way ANOVA/Kruskall–Wallis test
was performed followed by a Tukey’s post hoc test. Significance levels are indicated according to the legend ⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001.
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included an increase in hMSC numbers with increasing time of
culture in all three media conditions (0%, 5% and 10%). However,
a significantly greater number of hMSC were observed at day 7
in the control media in comparison with hMSC cultured in 5%
(v/v) and 10% (v/v) of p(HEMA-co-APMA) g PAA monomer in
media. A decrease in cell numbers of 6.33% and 10.6% was observed
in 5% (v/v) and 10% (v/v) pHEMA-APMA-PAA monomer in media,
respectively, at day 7, in comparison with cells cultured in control
media. A significant decrease in cell numbers was also observed
at day 14 with increasing concentration of p(HEMA-co-APMA) g
PAA monomer in culture media. A 19% decrease in cell numbers
was observed in 5% (v/v) p(HEMA-co-APMA) g PAA monomer in
media compared with cells cultured in control media, and a
11.5% decrease in cell numbers was observed in 10% (v/v)
p(HEMA-co-APMA) g PAA monomer in culture media.
3.5. Degradation profile under mechanical stimulation and mechanical
property characterization of acellular and cellular hydrogels
The degradation behaviour of acellular hydrogels was deter-
mined by evaluating their swelling behaviour (water uptake) and
weight loss, using the parameters calculated in Eqs. (1) and (2).Observations revealed, as expected, an increase in water uptake
from day 0 at 0% to a 467% increase at day 56 (Fig. 7A). As expected,
an increase in water uptake was a result of an observed weight loss
of these hydrogels, from 0% at day 0 to a 24.945% increase in
weight loss (Fig. 7B).
Acellular hydrogels (cultured in PBS) and hMSC encapsulated
hydrogels (cultured in hMSC and chondrogenic media) cultured
under hypoxic conditions were characterized for their mechanical
properties at day 7 and 14. Observations revealed a significant
decrease in dynamic stiffness of cellular hydrogels at day 7
cultured in hMSC media (0.994 MPa; p < 0.05) and in chondrogenic
media (0.929 MPa; p < 0.05) in comparison with acellular hydro-
gels kept in PBS also at day 7 (0.1272 MPa). Further significant
decreases in stiffness were observed at day 14 of cellular hydrogels
cultured in hMSC media (0.0775 MPa; p < 0.01) and in chondro-
genic media (0.0692 MPa; p < 0.01) in comparison with acellular
hydrogels (0.1198 MPa) (Fig. 8A).
Similar observations were also found for the elastic modulus
values where there was a significant decrease in the modulus of
cellular hydrogels at day 7, cultured in hMSC media (2.73 kPa;
p < 0.001) and in chondrogenic media (2.7 kPa; p < 0.001) in
comparison with acellular hydrogels cultured in PBS also at day
7 (4.23 kPa). Significant decreases were also observed in cellular
Fig. 3. Cell viability of encapsulated hMSC within p(HEMA-co-APMA) g PAA hydrogels: (A) live/dead staining of encapsulated hMSC expanded in both hMSC media and
chondrogenic media up to day 14 (scale bar = 200 lm); (B) quantification of cell viability using Alamar blue. Values indicate average number of viable cells and error bars
indicate SD for triplicate readings of three repeats for each sample type. Data were tested for normality and a one-way ANOVA/Kruskall–Wallis test was performed followed
by a Tukey’s post hoc test. Significance levels are indicated according to the legend ⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001.
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and in chondrogenic media (2.5168 kPa; p < 0.01) in comparison
with acellular hydrogels cultured in PBS at day 14 (3.7 kPa)
(Fig. 8B).4. Discussion
Disc degeneration occurs as a result of changes in the biochem-
ical process within NP cells. Changes in metabolic activity result in
a decrease in matrix production and an increase in matrix break-
down with changes in the ratio of keratin sulfate to chondroitin
sulfate, causing a decrease in proteoglycan content [26]. This ulti-
mately has an impact on the fixed charged density of NP tissue,
which decreases from 0.28 meq ml1 to 0.18–0.20 meq ml1,
resulting in a decrease in swelling properties and loss of disc height
[26]. Biochemical changes usually translate into biomechanical
changes such as alterations in stresses and strains, which lead to
further distortion and damage to the intervertebral disc (IVD).
The emerging therapy must allow tissue regeneration and
complete recovery of the NP tissue both biochemically and
biomechanically [26].
Currently, there are two in situ curable, polymers (Prosthetic
Intervertebral Nucleus, Disc Dynamics, Minnetonka and Biodisc,
Cryolife, Kennesaw) under development, and which have entered
clinical trials. However, these therapies are only limited to
restoring the height of the disc, but do not actually promote any
neo tissue matrix secretion and regeneration [26]. Injectable,in situ polymer hydrogels are of great interest for use in IVD repair,
specifically targeting the restoration of the disc height and regen-
eration of NP tissue through minimally invasive surgery. Injecting
stem cell (MSC) suspensions into NP tissue has demonstrated
survival and ability to differentiate into chondrocytes [27],
although issues have been reported, such as leakage of MSC into
the disc surroundings, causing osteophyte formation and no
improvement in disc height [28]. Therefore a preferred option
may be to encapsulate MSC into a carrier, such as a hydrogel, to
protect cell leakage, but also to provide the correct structural envi-
ronment to support MSC expansion and appropriate differentiation
[2]. Although nanofibrous substrates (poly-L-lactic acid) have
demonstrated an ability to increase the proliferative capacity of
NP cells and enhance matrix secretion (GAG and collagen type
II); a study by Feng et al. [29,30] explored the application of PLLA
nanofibrous scaffolds in the support of rabbit MSC differentiation
towards NP tissue under hypoxic conditions with TGF-b in
media. Despite demonstrating successful differentiation by the
up-regulation of typical markers, including aggrecan, collagen II
and sox-9, this study did not combine an important feature of
in vivo NP tissue, hydration, which hydrogels are able to do, while
providing other advantages such as injectability and introduction
via minimally invasive surgery [29,30].
Of the few studies that have attempted to use a photo-polymer-
ization technique to fabricate hydrogels for NP tissue engineering,
the present study is also an example where a novel, synthetic
polymer hydrogel, p(HEMA-co-APMA) g PAA, is modified to
provide relevant mechanical properties, increased swelling ability,
Fig. 4. Multipotent marker expression (Stro-1 and Thy-1) of hMSC encapsulated in p(HEMA-co-APMA) g PAA hydrogels and cultured on TCP in both hMSC and chondrogenic
media up to day 14. Scale bar = 100–200 lm (see individual images for specific scale).
Fig. 5. Chondrogenic marker expression (collagen II and aggrecan) of hMSC encapsulated in pHEMA-APMA-PAA hydrogels and cultured on TCP in both hMSC and
chondrogenic media up to day 14. Scale bar = 100–200 lm (see individual images for specific scale).
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Fig. 6. Evaluation of cytotoxicity effect of p(HEMA-co-APMA) g PAA monomers on hMSC expansion. (A) Live/dead staining of hMSC cultured on TCP in control media, 5% of
degradation product (DP) in hMSC media and 10% DP in hMSC media (scale bar = 200 lm). (B) Quantification of cell viability (MTT assay) during culture of hMSC in the
different media up to day 14. Values indicate average number of viable cells, and error bars indicate SD for triplicate readings of three repeats for each sample type. Data were
tested for normality and a one-way ANOVA/Kruskall–Wallis test was performed followed by a Tukey’s post hoc test. Significance levels are indicated according to the legend:
⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001.
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combining Irgacure 2959 in the polymer solution. Irgacure 2959
has proved to be cytocompatible [20] and has been used in
previous investigations, where photo-curable hydrogels were
produced from alginate, fibrin and carboxymethylcellulose [13].
In these studies, cells (NP cells and IVD cells of bovine origin) were
encapsulated and cultured in vitro, and displayed good cell viabil-
ity up to day 7, and pericellular deposition of chondroitin sulfate.
The present study also demonstrated good cell viability and no
toxic effect of Irgacure 2959 or the polymer hydrogel itself up
to 14 days in culture, with successful differentiation of hMSC into
chondrocyte-like cells using chondrogenic media indicated by
increased expression of aggrecan and collagen II.
Studies that have used UV for photo-curing of their polymer
hydrogels have all appeared to expose their cells and allow total
crosslinking to occur within 2–3 mins, though some studies have
used longer exposure times of up to 10 mins [31,32]. These studies,
along with the present study, have confirmed no significant
changes or damage to the cells as a result of UV exposure, validated
by cell viability assays. Furthermore, many of the studies used the
same parameters for UV energy, which is the Blak-Ray lamp
(Model B100AP) at an intensity of 10 mW cm2, which were
the exact parameters used in the present study for a maximumUV exposure time of 2.5 mins, which is also considered clinically
acceptable for in vivo applications [31]. However, there are serious
implications with using UV curable hydrogels, such as the risk of
genotoxicity effects of UV exposure to encapsulated hMSC, which
could result in genetic material modification and damage to
DNA. DNA double strand breaks can induce the expression of
!H2aX, an early detection marker of DNA damage [33,34]. The
present authors investigated the effect of increasing UV exposure
duration on hMSC DNA damage. It was observed that UV exposure
to hMSC beyond 10 mins resulted in the detection and accumula-
tion of !H2aX; however, insignificant differences were observed
between no UV exposure and 2.5 mins of UV exposure, thus sug-
gesting clinically acceptable levels of UV for hMSC encapsulation
in UV cured hydrogels without causing any DNA damage [33,34].
Furthermore, as the synthetic polymer hydrogel is expected to
degrade over time, it was proposed to determine the effects of
accumulated degraded by-products on cell viability. It was
observed that an increase in polymer degradation product in the
media at 5% and 10% (w/v) concentration might affect cell
proliferation to some extent, as evidenced by the slight decrease
in cell numbers observed after 7 and 14 days of treatment with
the degradation products. However, the main component of this
hydrogel is the pHEMA backbone, which is considered highly
Fig. 7. Degradation profile of acellular hydrogels under mechanical stimulation determined by evaluation of: (A) water uptake; (B) weight loss.
Fig. 8. Characterization of mechanical properties: (A) stiffness; (B) modulus values of both acellular and cellular hydrogels at day 7 and day 14 in culture. Values indicate
average stiffness or modulus values, and error bars indicate SD of n = 3 repeats. Data were tested for normality and a one-way ANOVA/Kruskall–Wallis test was performed
followed by a Tukey’s post hoc test. Significance levels are indicated according to the legend: ⁄p < 0.05, ⁄⁄p < 0.01 and ⁄⁄⁄p < 0.001.
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lenses as a successful clinical product with no toxic effects during
degradation [35]. Current clinical trials also include the investiga-
tion of pHEMA applications in ophthalmic surgery, dentistry and
controlled drug delivery [36]. The other component of the hydrogel
is PAA; degradation products of PAA also have a long history of
biocompatibility and non-toxicity to various cells [37] and have
been investigated for their use in many cellular activities, including
mediating the efficient transfection of cells in culture [38,39]. A
recent systematic study on the cytotoxicity of the degradation
products of PAA copolymerized with PHEMA segments was
assessed by Martello et al. [40] showing good biocompatibility.
With this evidence in mind, it can be anticipated that the polymer
hydrogel should show minimal cytotoxicity. Further to this, the
hydrogel has been designed to degrade with degradation products
<20 kDa (limit for renal filtration), which permits the ability to
excrete these polymer by-products through the metabolic pathway
efficiently, thus preventing localized accumulation of hydrogel
by-products even in long term [40]. However, this proof of concept
would have to be further validated by performing future in vivo
experiments, which would be long term, where the cytotoxicity
effects would be investigated in detail.
The advantages of using photo-curing as a method of hydrogel
production include: short reaction times (as demonstrated in the
present study; 2.5 mins); minimal heating; no organic solvents;
and the convenience of tuning the mechanical properties and
swelling behaviour of materials [15]. Using natural polymers, it is
very difficult to fine-tune their mechanical properties and swelling
behaviour, similar to native NP tissue, which is soft, extremely
hydrated and has an elastic modulus ranging between 3 and
6 kPa [15,41]. This study has shown that the novel synthetic
p(HEMA-co-APMA) g PAA hydrogel can encapsulate hMSC in situ
and support their growth and differentiation to cartilage-like cells.
It has been well reported that stem cell differentiation can be
affected by the mechanical properties of substrates supporting cell
attachment and growth [42–45]. It is therefore anticipated that the
polymer hydrogel used in the current study with mechanical
properties similar to native NP tissue would not only function as
a temporal mechanical support at the implantation site, but also
facilitate the differentiation of encapsulated stem cells towards a
phenotype similar to NP cells. This statement is further strength-
ened by a previous study that also proposes a similar hydrogel to
function appropriately as a scaffold for NP regeneration [46].
Furthermore, it is promising to note an insignificant decrease in
mechanical properties even after 14 days’ degradation of acellular
hydrogels in PBS. However, once hMSCwere encapsulated in hydro-
gels and cultured in hMSC or chondrogenic media, a significant
decrease in stiffness and modulus was also observed after 14 days
in comparison with acellular hydrogels. The reason for such behav-
iour is likely to be a result of polymer degradation occurring through
hydrolysis. It is very unlikely that the degradation was accelerated
through enzyme-induced degradation as a result of incorporating
biological material into the hydrogel, as no peptide crosslinker
was presented in the polymer used in the current study. The
influence of cells encapsulated within the hydrogel and the
presence of serum on the degradation rate of hydrolytically
biodegradable PLA and PEG-PLA-based gels has also been reported
[47]. In addition, as no dramatic difference was noticed in medium
containing 10% (hMSC media) and 1% (chondrogenic) FBS, the
effects of proteases present in serum could be excluded. It has been
demonstrated that PAA degradation is pH dependent, with a
very significant increase in hydrolysis rate at reduced pH [48].
Considering that the cellular hydrogel was cultured in a hypoxic
environment, it was anticipated that the increased lactate produc-
tion as the consequence of anaerobic metabolism [49] could cause
acidification in the immediate area of the cells and accelerate therate of hydrolysis and degradation, and the reduction of mechanical
properties compared with acellular samples. As it has been
confirmed that degenerative IVD have a more acidic ECM
environment [50], it could be hypothesized that the rate of polymer
hydrogel degradation in vivo could exceed the rate of neo matrix
formation, and therefore further fine-tuning may be required to
slow down polymer degradation to compensate for the slow rate
of matrix production. Furthermore, a population of cells may be in
a state of quiescence once encapsulated, as reported previously by
Fedorovich et al. [51], which could explain the slower rate of matrix
production. In any case, such a decline in the mechanical properties
could be compensated by adjusting the polymer concentration;
future work would be required to validate such changes in cell
viability and differentiation, as these activities can also be affected
by substrate stiffness [42].
The combined effects of hydrogel environment, hypoxia and
chemical media on hMSC differentiation towards a chondrocyte-
like cell were investigated in this study. It has been reported
previously that hypoxic culture of hMSC encapsulated in alginate
beads with chondrogenic media containing growth and differentia-
tion factor-5 enhanced chondrogenic differentiation, but co-culture
with bovine NP cells had little effect [9]. However, this study is the
first to use a photocurable hydrogel in combination with hypoxic
and chondrogenic media in culture, which also demonstrated
successful differentiation of hMSC towards a chondrocyte-like
lineage investigated by typical markers, collagen II and aggrecan,
as used previously by others [9]. The precise differentiation of hMSC
towards an NP cell type could have been further validated by
evaluating the expression of additional markers such as HIF-1. In
addition, the ratio of PG to collagen II could also have been
quantified, which has recently been revealed to be different
between NP tissue (27:1) and articular cartilage (2:1) [52].
However, the application of this hydrogel and study was to provide
a biomaterial that would act as an encapsulation cell carrier, to
provide mechanical support, not only to the cells, but also to the
surrounding tissue in vivo and, more importantly, to provide a
means of delivering the cells in a minimally invasive procedure to
the target site, where photo-curing of the hydrogel would take
place in vivo rather than prior to implantation. Thereafter, the
present authors anticipate that the differentiation process of hMSC
towards NP tissuewould solely be reliant on cues signalled from the
native in vivo tissue environment itself.
It is believed that, by mimicking the structural environment and
the hydrated state of NP tissue using the hydrogel, and by provid-
ing the typical growth factors in chondrogenic media such as TGF-b
and the hypoxic environment, which induces transcriptional
changes in hMSC, it was possible to elicit an increased expression
of aggrecan and collagen II as a result of outside-in and inside-
out signalling between the cells and their environment, and would
eventually lead to a subsequent secretion and production of NP-
like tissue matrix.
In summary, this study has demonstrated the successful 3-D
encapsulation, expansion and differentiation of bone marrow-
derived hMSC in novel, synthetic polymer p(HEMA-co-APMA) g
PAA hydrogels under hypoxic conditions. The combined effects of
hydrogel structure, hypoxic conditions and chemical cues have
all contributed towards promoting the differentiation of hMSC
towards a chondrogenic cell lineage. Owing to short curing times
via photo-crosslinking and relevant mechanical properties, this
hydrogel has good potential as an injectable therapy, which is
minimally invasive for in vivo NP tissue replacement.
5. Conclusion
This study investigated the potential for a novel, photo-curable
synthetic polymer p(HEMA-co-APMA) g PAA for the 3-D
D. Kumar et al. / Acta Biomaterialia 10 (2014) 3463–3474 3473encapsulation, expansion and differentiation of bone marrow-
derived hMSC under hypoxic conditions. This study confirmed
good cell viability, polymer biocompatibility and little effect on
genotoxicity as a result of UV exposure to encapsulated cells
within hydrogels. Furthermore, the 3-D encapsulation within the
hydrogel network, chemical and hypoxic cues supported their dif-
ferentiation towards a chondrogenic lineage with elevated levels of
collagen II and aggrecan. Characterization of mechanical properties
of the hydrogels deciphered appropriate stiffness and modulus
values of acellular hydrogels for the application in NP tissue repair.
This injectable, photocurable hydrogel shows good potential for
future in vivo NP applications, which can not only restore the
disc height with relevant mechanical properties, but also has the
opportunity to deliver therapeutic agents such as hMSC.Acknowledgements
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